Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004048255 | SCV002620040 | uncertain significance | not specified | 2021-10-20 | criteria provided, single submitter | clinical testing | The p.I129S variant (also known as c.386T>G), located in coding exon 2 of the IDH1 gene, results from a T to G substitution at nucleotide position 386. The isoleucine at codon 129 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |